 |
0 Diseases |  |
0 Trials |
|
0 Trials |  |
6 News |  |
- || SAN-300 / Bausch Health
3.000 palabras, con suerte usan 300 ermanoh.!! (Twitter) - Oct 1, 2022
- | SAN-300 / Bausch Health
Trial completion, Trial primary completion date: (C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis (clinicaltrials.gov) - Apr 27, 2017
P2, N=41, Completed, Sponsor: Valeant Pharmaceuticals International, Inc.
Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Feb 2017
- | SAN-300 / Bausch Health
Enrollment change, Trial primary completion date: (C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis (clinicaltrials.gov) - Sep 4, 2014
P2, N=40, Recruiting, Sponsor: Salix Pharmaceuticals
Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Feb 2017 N=90 --> 40 | Trial primary completion date: Jan 2015 --> Jun 2016
- ||||| SAN-300 / Bausch Health
New P2 trial: (C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis (clinicaltrials.gov) - Jan 26, 2014
P2, N=90, Recruiting, Sponsor: Salix Pharmaceuticals